Chanchai Boonla

1.5k total citations
50 papers, 1.1k citations indexed

About

Chanchai Boonla is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Surgery. According to data from OpenAlex, Chanchai Boonla has authored 50 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Molecular Biology, 18 papers in Pulmonary and Respiratory Medicine and 6 papers in Surgery. Recurrent topics in Chanchai Boonla's work include Kidney Stones and Urolithiasis Treatments (17 papers), Glycosylation and Glycoproteins Research (6 papers) and Therapeutic Uses of Natural Elements (6 papers). Chanchai Boonla is often cited by papers focused on Kidney Stones and Urolithiasis Treatments (17 papers), Glycosylation and Glycoproteins Research (6 papers) and Therapeutic Uses of Natural Elements (6 papers). Chanchai Boonla collaborates with scholars based in Thailand, Japan and Germany. Chanchai Boonla's co-authors include Piyaratana Tosukhowong, Kriang Tungsanga, Apiwat Mutirangura, Thasinas Dissayabutra, Sopit Wongkham, Chaisiri Wongkham, Vajarabhongsa Bhudhisawasdi, Anapat Sanpavat, Pisit Tangkijvanich and John K. Sheehan and has published in prestigious journals such as PLoS ONE, The Science of The Total Environment and Cancer.

In The Last Decade

Chanchai Boonla

49 papers receiving 1.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Chanchai Boonla Thailand 22 472 325 222 132 104 50 1.1k
Akira Nishio Japan 21 315 0.7× 100 0.3× 103 0.5× 101 0.8× 134 1.3× 129 1.3k
Yubo Yang China 17 362 0.8× 267 0.8× 298 1.3× 148 1.1× 45 0.4× 83 1.2k
Purvi Purohit India 18 295 0.6× 61 0.2× 74 0.3× 122 0.9× 94 0.9× 95 1.2k
Paleerath Peerapen Thailand 20 402 0.9× 685 2.1× 48 0.2× 48 0.4× 48 0.5× 58 1.1k
Pi-Yueh Chang Taiwan 8 526 1.1× 80 0.2× 71 0.3× 52 0.4× 96 0.9× 10 1.4k
Asokan Devarajan United States 21 392 0.8× 127 0.4× 103 0.5× 61 0.5× 125 1.2× 38 1.2k
Ilijana Grigorov Serbia 15 283 0.6× 170 0.5× 67 0.3× 68 0.5× 82 0.8× 60 790
Yongsheng Fan China 24 679 1.4× 89 0.3× 84 0.4× 156 1.2× 241 2.3× 116 1.6k
Bing Gao China 23 490 1.0× 318 1.0× 448 2.0× 56 0.4× 102 1.0× 80 1.6k
Alberto López-Reyes Mexico 18 411 0.9× 67 0.2× 138 0.6× 74 0.6× 141 1.4× 76 1.3k

Countries citing papers authored by Chanchai Boonla

Since Specialization
Citations

This map shows the geographic impact of Chanchai Boonla's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chanchai Boonla with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chanchai Boonla more than expected).

Fields of papers citing papers by Chanchai Boonla

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chanchai Boonla. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chanchai Boonla. The network helps show where Chanchai Boonla may publish in the future.

Co-authorship network of co-authors of Chanchai Boonla

This figure shows the co-authorship network connecting the top 25 collaborators of Chanchai Boonla. A scholar is included among the top collaborators of Chanchai Boonla based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chanchai Boonla. Chanchai Boonla is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Gianvincenzo, Paolo Di, Nuntaporn Kamonsutthipaijit, Heinz Amenitsch, et al.. (2024). Supramolecular citrate poly allylamine hydrochloride nanoparticles for citrate delivery and calcium oxalate nanocrystal dissolution. Journal of Colloid and Interface Science. 669. 667–678. 2 indexed citations
2.
Gianvincenzo, Paolo Di, et al.. (2024). Enhanced anticancer activity of N,N-bis(5-ethyl-2-hydroxybenzyl)methylamine (EMD) hydrophobic drug encapsulated in β-cyclodextrin nanosponges. Colloids and Interface Science Communications. 62. 100803–100803. 2 indexed citations
3.
Gianvincenzo, Paolo Di, et al.. (2023). A study of cyanidin/alginate complexation: Influence of pH in assembly and chiral properties. Carbohydrate Polymers. 315. 120957–120957. 2 indexed citations
4.
Jagota, Priya, et al.. (2022). Umami and Other Taste Perceptions in Patients With Parkinson’s Disease. Journal of Movement Disorders. 15(2). 115–123. 8 indexed citations
5.
Prasanth, Mani Iyer, et al.. (2022). HydroZitLa inhibits calcium oxalate stone formation in nephrolithic rats and promotes longevity in nematode Caenorhabditis elegans. Scientific Reports. 12(1). 5102–5102. 7 indexed citations
7.
Suzuki, Satoru, Hideshige Takada, Kaoruko Mizukawa, et al.. (2021). Contamination of antibiotics and sul and tet(M) genes in veterinary wastewater, river, and coastal sea in Thailand. The Science of The Total Environment. 791. 148423–148423. 29 indexed citations
8.
Jindatip, Depicha, Anapat Sanpavat, Wolfgang A. Schulz, et al.. (2018). LINE-1 ORF1 Protein Is Up-regulated by Reactive Oxygen Species and Associated with Bladder Urothelial Carcinoma Progression. Cancer Genomics & Proteomics. 15(2). 143–151. 21 indexed citations
9.
Dissayabutra, Thasinas, et al.. (2018). Urinary stone risk factors in the descendants of patients with kidney stone disease. Pediatric Nephrology. 33(7). 1173–1181. 12 indexed citations
10.
Sanpavat, Anapat, et al.. (2017). Oxidative stress indicated by elevated expression of Nrf2 and 8-OHdG promotes hepatocellular carcinoma progression. Medical Oncology. 34(4). 57–57. 66 indexed citations
11.
Kittikowit, Wipawee, et al.. (2014). Increased oxidative DNA damage seen in renal biopsies adjacent stones in patients with nephrolithiasis. Urolithiasis. 42(5). 387–394. 18 indexed citations
12.
Chuaypen, Natthaya, et al.. (2013). Increased intrarenal expression of sodium-dicarboxylate cotransporter-1 in nephrolithiasis patients with acidic urine pH.. Asian Biomedicine. 7(4). 571–577. 3 indexed citations
13.
Patchsung, Maturada, et al.. (2012). Long Interspersed Nuclear Element-1 Hypomethylation and Oxidative Stress: Correlation and Bladder Cancer Diagnostic Potential. PLoS ONE. 7(5). e37009–e37009. 60 indexed citations
14.
Tosukhowong, Piyaratana, et al.. (2010). Crystalline composition and etiologic factors of kidney stone in Thailand : update 2007. Asian Biomedicine. 1(1). 87–95. 14 indexed citations
15.
Srimahachota, Suphot, et al.. (2010). Effects of lifestyle modification on oxidized LDL, reactive oxygen species production and endothelial cell viability in patients with coronary artery disease. Clinical Biochemistry. 43(10-11). 858–862. 19 indexed citations
16.
Boonla, Chanchai, et al.. (2008). Messenger RNA expression of monocyte chemoattractant protein‐1 and interleukin‐6 in stone‐containing kidneys. British Journal of Urology. 101(9). 1170–1177. 47 indexed citations
17.
Tosukhowong, Piyaratana, et al.. (2008). Citraturic, alkalinizing and antioxidative effects of limeade-based regimen in nephrolithiasis patients. Urological Research. 36(3-4). 149–155. 32 indexed citations
18.
Bunchu, Nophawan, et al.. (2006). A new mucin antibody/enzyme-linked lectin-sandwich assay of serum MUC5AC mucin for the diagnosis of cholangiocarcinoma. Cancer Letters. 247(2). 301–308. 51 indexed citations
19.
Boonla, Chanchai, Sopit Wongkham, John K. Sheehan, et al.. (2003). Prognostic value of serum MUC5AC mucin in patients with cholangiocarcinoma. Cancer. 98(7). 1438–1443. 52 indexed citations
20.
Wongkham, Sopit, et al.. (2001). Serum total sialic acid in cholangiocarcinoma patients: an ROC curve analysis. Clinical Biochemistry. 34(7). 537–541. 30 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026